Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses.

Powers, John M; Haese, Nicole N; Denton, Michael; Ando, Takeshi; Kreklywich, Craig; Bonin, Kiley; Streblow, Cassilyn E; Kreklywich, Nicholas; Smith, Patricia; Broeckel, Rebecca; DeFilippis, Victor; Morrison, Thomas E; Heise, Mark T; Streblow, Daniel N

Powers, John M; Haese, Nicole N; Denton, Michael; Ando, Takeshi; Kreklywich, Craig; Bonin, Kiley; Streblow, Cassilyn E; Kreklywich, Nicholas; Smith, Patricia; Broeckel, Rebecca; DeFilippis, Victor; Morrison, Thomas E; Heise, Mark T; Streblow, Daniel N.

Affiliation

Powers JM; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Haese NN; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon, United States of America.
Denton M; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Ando T; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Kreklywich C; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Bonin K; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Streblow CE; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Kreklywich N; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Smith P; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Broeckel R; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
DeFilippis V; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Morrison TE; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Heise MT; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
Streblow DN; Department of Genetics, Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

PLoS Negl Trop Dis ; 15(4): e0009308, 2021 04.

Article de En | MEDLINE | ID: mdl-33793555

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins antiviraux / Adenoviridae / Virus du chikungunya / Alphavirus / Fièvre chikungunya Type d'étude: Prognostic_studies Limites: Animals Langue: En Journal: PLoS Negl Trop Dis Sujet du journal: MEDICINA TROPICAL Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google